News about Covid-19, booster

Pronounced benefit of Paxlovid in hospitalized patients out to year vs #LongCovid sequelae, including survival www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00217-2/fulltext @TheLancetInfDis More pronounced for age 65+ and those with 3-dose vaccination. Graph at right is post 21-day mortality pic.twitter.com/GL7ZoNPTfZ

The public health emergency order for COVID-19 may have been lifted, but that doesn't mean COVID-19 has gone away. Pfizer is partnering in new ways to help connect patients with the education and services they need to stay healthy and safe. Learn how: on.pfizer.com/3UiGWOw pic.twitter.com/sDYLYjXYiM

We shared @Pfizer’s 2024 Q1 results today. We had a solid start to the year, and I’m proud that in the first three months, we reached more than 119M patients* with our medicines and vaccines. Additionally, we have made notable progress on our five strategic priorities, from… pic.twitter.com/5zCDxK4J9j

iNews: “Cases involving FLiRT variants have soared to account for ¼ of all UK COVID infections. At the same time, the immunity from vaccines and previous infections is likely to be waning after months of very low levels of the virus.”👇 inews.co.uk/news/science/new-flirt-covid-variants-new-wave-3030595